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Abstract 
The quantity and quality of bone depends on osteoblastic differentiation of mesenchymal stem 
cells (MSCs), where adipogenic commitment depletes the available pool for osteogenesis. Cell 
architecture influences lineage decisions, where interfering with cytoskeletal structure promotes 
adipogenesis. Mechanical strain suppresses MSC adipogenesis partially through RhoA driven 
enhancement of cytoskeletal structure. To understand the basis of force-driven RhoA activation, 
we considered critical GEFs (activators) and GAPs (inactivators) on bone marrow MSC lineage 
fate. Knockdown of LARG accelerated adipogenesis and repressed basal RhoA activity. 
Importantly, mechanical activation of RhoA was almost entirely inhibited following LARG 
depletion, and the ability of strain to inhibit adipogenesis was impaired. Knockdown of 
ARHGAP18 increased basal RhoA activity and actin stress fiber formation, but did not enhance 
mechanical strain activation of RhoA. ARHGAP18 null MSCs exhibited suppressed 
adipogenesis assessed by Oil-Red-O staining and Western blot of adipogenic markers. 
Furthermore, ARHGAP18 knockdown enhanced osteogenic commitment, confirmed by alkaline 
phosphatase staining and qPCR of Sp7, Alpl, and Bglap genes. This suggests that ARHGAP18 
conveys tonic inhibition of MSC cytoskeletal assembly, returning RhoA to an “off state” and 
affecting cell lineage in the static state. In contrast, LARG is recruited during dynamic 
mechanical strain, and is necessary for mechanical suppression of adipogenesis. In summary, 
mechanical activation of RhoA in mesenchymal progenitors is dependent on LARG, while 
ARHGAP18 limits RhoA delineated cytoskeletal structure in static cultures. Thus, on and off 
GTP exchangers work through RhoA to influence MSC fate and responses to static and 
dynamic physical factors in the microenvironment. 
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Introduction 
Bone marrow mesenchymal stem cells (MSCs) contribute to bone structure and strength by 
serving as a pool for osteoprogenitors. Conditions of disuse, such as bed rest, immobilization 
due to disability, or a sedentary lifestyle increase marrow adiposity[1]. Conversely, exercise in 
vivo, as well as mechanical loading in vitro, are associated with a reduction in marrow 
adipocytes and increased bone formation [2-9]. These changes are attributed in part to 
mechanical biasing of MSCs away from the adipogenic lineage, providing a larger number of 
cells available for osteogenesis[10]. While there are numerous cues, including hormonal and 
spatial signaling that govern MSC fate, mechanical force activates several critical pathways 
leading to adipogenic repression[11]. A central regulator of MSC fate is -catenin, which 
promotes maintenance of pluripotency[12]. We have shown that mechanical strain prevents 
proteasomal degradation of -catenin by phosphorylation of GSK3-, thus allowing -catenin to 
restrict adipogenic gene transcription[13]. Furthermore, activation of GSK3- requires 
phosphorylation by Akt[14], a direct substrate of the Rictor-associated mTor complex 
mTORC2[15]. In addition to preservation of -catenin, our lab showed that activation of 
Akt/mTORC2 was necessary for downstream RhoA activity, a critical regulator of actin stress 
fiber formation, originating at focal adhesions (FAs)[5]. 
Mechanical activation of mTORC2 requires tension across FAs. Disruption of FAs impairs 
mTORC2/Akt signaling and leads to increased adipogenic differentiation[16]. Conversely, 
mechanical strain increases numbers of FAs, thus amplifying downstream signaling[17]. We 
have shown that signal amplification is preceded by spatial recruitment of both Fyn and FAK to 
FAs, where coordinated activation of mTORC2 occurs at the cell membrane[5]. Thus, 
mechanical force acts through FAs by compartmentalizing signaling effectors to sites of force 
transmission to activate -catenin, leading to decreased adipogenic commitment. In addition to 
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converging on -catenin, mTORC2 signaling is necessary for mechanical assembly of actin 
stress fibers, in both MSCs [5, 16] and other cell types [18, 19]. 
The actin cytoskeleton creates a framework, spanning FA contact points, through which 
diverse functions take place. Actin stress fibers serve as a structural scaffold, through which 
cellular stiffness is regulated and intracellular signals move, dock, and activate downstream 
signaling[20]. Static mechanical cues, such as alteration of substrate stiffness or changing cell 
shape, influence MSC fate, and are partially dependent on RhoA-directed development of 
cytoskeletal structure [21]. In a similar fashion, dynamic application of mechanical force also 
activates RhoA to enhance actin stress fiber formation[5, 7]. We have shown that mTORC2/Akt 
signaling is required for mechanical activation of RhoA in MSCs[5]; however, the direct 
regulators of RhoA activation in response to dynamic mechanical strain remain unknown. 
RhoA is a GTPase, inactive when guanine diphosphate (GDP) is bound and active when it 
binds guanine triphosphate (GTP) [22]. The on/off state of RhoA is governed by guanine 
nucleotide exchange factors (GEFs), which promote the GTP-bound active state, and GTPase 
activating proteins (GAPs), which stimulate GTP hydrolysis, resulting in GDP-bound (inactivate ) 
RhoA[23]. Previous work has shown that stimulation of integrins with tensional force in mouse 
embryonic fibroblasts (MEFs) induced recruitment of two GEFs to FA complexes, leukemia 
associated RhoGEF (LARG) and GEF-H1 with subsequent RhoA activation [24]. Activation of 
LARG required the Src-like kinase Fyn, while GEF-H1 activity was ERK1/2 dependent[24]. As 
we have shown that Fyn is necessary for mTORC2-mediated RhoA activation in MSCs, and that 
ERK1/2 is not involved in this cascade[5], we hypothesized that LARG would be responsible for 
RhoA activation in response to mechanical strain. We also sought to determine which GAP(s) 
are necessary for balancing RhoA activity by allowing RhoA to cycle back to an inactive state. 
ARHGAP18, an understudied GAP, controls cell shape, spreading, and motility in fibroblasts 
and MDA-MB-231 human breast cancer cells[25]. Additionally, knockdown of ARHGAP18 
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induced sustained RhoA activation, leading us to consider that ARHGAP18 influences RhoA 
activity in MSCs, thus balancing the activity of Rho GEFs to help “reset” RhoA[25]. 
In this work, we used murine marrow-derived MSCs to determine the role of Rho GEFs and 
GAPs on mechanical activation of RhoA and how these GTP exchangers influence RhoA 
activity to alter MSC fate. We show that mechanical activation of RhoA, and subsequent 
formation of actin stress fibers requires the GEF LARG. Additionally, mechanical repression of 
adipogenesis was blunted in the absence of LARG, suggesting that this GEF is a critical GTP 
exchanger for RhoA-mediated cytoskeletal remodeling in MSCs. We also demonstrated that 
knockdown of the Rho GAP, ARHGAP18, restricts entry of MSCs into the adipogenic lineage, 
while promoting osteogenesis. These signals provide reciprocal balance of RhoA activity in 
MSCs, representing critical control switches to influence lineage decisions. Such factors may be 
targets for pharmacological or physical therapeutic interventions to enhance bone formation and 
strength. 
Materials and Methods 
Reagents 
 Fetal bovine serum (FBS) was obtained from Atlanta Biologicals (Atlanta, GA). Culture 
media, trypsin-EDTA, antibiotics, and phalloidin-Alexa488 were purchased from Invitrogen 
(Carlsbad, CA). Insulin, dexamethasone, and indomethacin were purchased from Sigma Aldrich 
(St. Louis, MO). ROCK inhibitor Y27632 was purchased from Sigma Aldrich (St. Louis, MO). 
Rhosin inhibitor was purchased from EMD Millipore (Billerica, MA). 
siRNA-Mediated Knockdown 
 mdMSCs were transfected with gene-specific siRNA or control siRNA (20 nM) using 
PepMute Plus transfection reagent (SignaGen Labs, Rockville, MD). Medium was replaced at 
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18 hours with IMDM containing FBS (10%, v/v) and penicillin/streptomycin (100 g/ml). 
Mechanical strain was applied 72 hours after initial transfection; adipogenic media were added 
18 hours after transfection. The following Stealth Select siRNAs (Invitrogen) were used in this 
study: negative control 5’-CCACUCCCAUUCGGUUACUUAGGAA-3’; LARG 5’-
CCAGAUCCCACUUGCUGAUUCUGAA-3’; Vav2 5’-ACAAGCAGCAGCUUCUCUUGUCGUC-
3’. Stable knockdown of Arhgap18 was achieved using lentiviral infection of the pLKO.1 plasmid 
containing shRNA sequence 5’-AATTGATCGATCAAATGGAGG-3’, targeting Arhgap18 
(Thermo Scientific). Briefly, lenti virus particles were packaged by the UNC Lenti-shRNA core 
facility according to the manufacturer’s instructions. Lentiviral particles were added to 
subconfluent MSC cultures in a 100 cm dish and incubated at 37°C for 48 hrs. Puromycin (20 
μg/ml) was then added to select for cells infected with the lentiviral shRNA construct. Media was 
changed every 48 hrs, with puromycin, until cells grew to 80% confluence. Cells were 
maintained in IMDM media with puromycin (10 μg/ml); however, fresh media without puromycin 
was added 24 hours before initiation of experiments. 
Antibodies 
 Anti-RhoA antibody (sc-418) was purchased from Santa Cruz Biotechnology (Dallas, TX). 
Antibodies recognizing aP2 (XG6174) and alpha-tubulin (PM-7627) were purchased from 
ProSci, Inc. (Poway, CA). The anti-adiponectin antibody (PA1-054) was from Affinity 
BioReagents (Rockford, IL). Antibodies recognizing perilipin (#9349) and Pparγ (#2443) were 
purchased from Cell Signaling (Danvers, MA). The Vav2 antibody (ab52640) was from Abcam 
(Cambridge, MA). The LARG antibody was a gift from Dr. Kozo Kaibuchi (Nagoya University, 
Japan), while Dr. Takeshi Senga (Nagoya University, Japan) provided the Arhgap18 antibody. 
Cells and Culture Conditions 
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 Marrow-derived mesenchymal stem cells (mdMSCs) were isolated from 8-10 week old 
C57BL/6 male mice as previously described[26] [27], and maintained in Iscove’s Modified 
Dulbecco’s Medium (IMDM) with FBS (10%, v/v) and penicillin/streptomycin (100 μg/ml). For 
experiments, cells were plated at a density of 6,000–10,000 cells/cm2 on collagen-I coated 
silicone membrane plates (Flexcell International, Hillsborough, NC) and cultured for 2-4 days 
before beginning experiments. Cells were serum starved overnight in alpha-Minimal Essential 
Medium (α-MEM) prior to all assays. Adipogenic medium included dexamethasone (0.1 μM), 
insulin (5 μg/ml) and indomethacin (50 μM). The Y27632 (10 μM) inhibitor was added one hour 
prior to strain assays. 
Mechanical Strain 
 Uniform equibiaxial strain was applied to mdMSCs plated on six-well Bioflex Collagen-I 
coated plates using the Flexcell FX-4000 system (Flexcell International). A regimen of 2% strain 
was delivered at 10 cycles per minute for a total of 100 cycles (10 min) for RhoA activity assays 
and phosphorylation induction experiments. As development of adipogenesis requires at least 3 
days, we subjected MSC during differentiation to 2% strain for 6 hours a day for 3 days. This 
regimen was used as it was previously reported to be sufficient to restrict adipogenic 
differentiation of MSCs[28]. Cells used for phosphorylation induction and RhoA activity assays 
were lysed directly following the 100 cycles of strain, whereas cells stained for actin 
cytoskeleton were allowed to rest for 3 hrs following 100 cycles of strain to allow for actin stress 
fiber formation. 
Western Blotting 
 Whole cell lysates were prepared using radio immunoprecipitation assay (RIPA) lysis buffer 
(150 mM NaCl, 50 mM Tris HCl, 1 mM EGTA, 0.24% sodium deoxycholate,1% Igepal, pH 7.5) 
containing 25 mM NaF and 2 mM Na3VO4. Aprotinin, leupeptin, pepstatin, and 
phenylmethylsulfonylfluoride (PMSF) were added before each lysis. Whole cell lysates (20 μg) 
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were separated polyacrylamide gels (7, 9 or 12%) and transferred to polyvinylidene difluoride 
(PVDF) membranes. Membranes were blocked with milk (5%, w/v) diluted in TBS-T. Blots were 
then incubated overnight at 4˚C with the appropriate primary antibodies. Blots were washed and 
incubated with horseradish peroxidase-conjugated secondary antibody (1:5,000 dilution) (Cell 
Signaling) at room temperature (RT) for one hour. Chemiluminescence was detected with ECL 
plus (Amersham Biosciences, Piscataway, NJ) and developed. Images were acquired with a 
Hewlett Packard Scanjet scanner, and densitometry was determined using ImageJ software 
version 1.45s (NIH). 
RhoA Assay 
 Purification of recombinant proteins and construction of the pGEX4T-1 prokaryotic 
expression constructs containing the Rho-binding domain (RBD) of Rhotekin has been 
described[29]. Briefly, expression of the fusion proteins in Escherichia coli was induced using 
isopropyl β-D-1-thiogalactopyranoside (100 μM) for 12-16 hours at RT. Bacterial cells were 
lysed in lysis buffer containing Tris HCl (50 m , pH 7.6), NaCl (150 mM), MgCl2 (5 mM), 
dithiothreitol (1 mM), aprotinin (10 μg/ml), leupeptin (10 μg/ml), and PMSF (1 mM). 
Recombinant proteins were purified by incubation with glutathione-sepharose 4B beads (GE 
Healthcare, Piscataway, NJ) at 4˚C. Pull down of active RhoA, using glutathione S-transferase-
RBD (GST-RBD) beads, was performed as described[30]. mdMSC cells were lysed in buffer 
containing Tris HCl (50 mM, pH 7.6), NaCl (500 mM), Triton X-100 (1%, v/v), SDS (0.1%, v/v), 
sodium deoxycholate (0.5%, w/v), MgCl2 (10 mM), orthovanadate (200 μM), and protease 
inhibitors. Lysates were clarified by centrifugation, equalized for total volume and protein 
concentration and rotated at 4˚C for 30 minutes with 50 μg of purified GST-RBD bound to 
glutathione-sepharose beads. The bead pellets were washed in lysis buffer, followed by 
pelleting of the beads by centrifugation, and subsequently processed by SDS-PAGE. 
 
Immunofluorescence 
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 Following strain and/or treatment with pharmacological inhibitors, cells were fixed with 
paraformaldehyde (4%, v/v) for 20 min, permeabilized with Triton X-100 (0.1%, v/v) for 5 min at 
RT, and donkey serum (5%, v/v) blocking buffer diluted in TBS-T was added for 30 min to block 
non-specific epitopes, as previously described[31]. The silicone culture membranes were 
detached from the BioFlex plates using a scalpel and transferred to wells of six-well plates. 
Cells were incubated with phalloidin-conjugated Alexa Fluor-488 (Invitrogen) diluted in TBS 
(1:100) 30 min at RT. Cells were washed and the silicone membranes were set on glass slides, 
covered, and sealed with mounting medium containing DAPI (Invitrogen). The number of actin 
stress fibers were quantified in phalloidin stained cells[32]. Briefly, using ImageJ, a line profile 
was placed across each cell, generating an output corresponding to the peak signal intensity as 
a function of distance across the cell. Sharp peaks in fluorescence intensity within each line 
profile represented individual stress fibers. Peak intensity was quantified in 3 different regions 
per cell, in at least 10 cells per condition. 
Statistical Analysis 
 Statistical variance was expressed as the means ±SE. Statistical significance was evaluated 
using a natural log transformation of the data to make the distribution more symmetric, followed 
by analysis using either a t-test or a two-way ANOVA, allowing for unequal variance (Prism 
GraphPad, La Jolla, CA). Values were considered significant if p was less than or equal to 0.05. 
Experiments were replicated at least three times to assure reproducibility. Densitometry data, 
where given, were compiled from at least three separate replicates. 
 
Results 
LARG is required for mechanical activation of RhoA in MSCs 
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 Our prior work demonstrated that 100 cycles of equibiaxial mechanical strain was sufficient 
to induce actin cytoskeletal stress fiber formation and RhoA activation in MSCs [5, 7, 33]. Here 
we asked whether the GEF LARG, implicated in tensional activation of RhoA[24] was required 
for mechanically-induced RhoA activation in MSCs. Following treatment with either a control 
siRNA or siRNA directed against LARG, MSCs were subject to 100 strain cycles (2%, 10 
cycles/min). LARG replete cells demonstrated a significant (p<0.05) increase of 3.32-fold in 
RhoA activity, as assessed by GTP-bound RhoA (Fig. 1A). Conversely, mechanical strain had 
no statistically significant effect on RhoA activation following siRNA-mediated silencing of LARG 
(Fig. 1A). The role of Vav2, another Rho GEF, on mechanical activation of RhoA was also 
assessed, as previous work showed that stretch-induced RhoA activation in mesangial cells 
required Vav2[34]. Our results showed that siRNA knockdown of Vav2 in MSCs did not prevent 
activation of RhoA in response to mechanical strain (Fig. 1B), supporting that LARG is the 
primary GEF controlling force-mediated RhoA activity in MSCs.  
 To explore the contribution of LARG on actin stress fiber formation, MSCs were strained for 
10 minutes followed by a 3 hr rest period prior to staining with Alexafluor-488 conjugated 
Phalloidin. Compared to static controls (Fig. 1C) 100 cycles of strain was sufficient to enhance 
actin stress fibers across the cell (Fig. 1D). Treatment with siRNA targeting LARG reduced actin 
staining in both static (Fig. 1 ) and strained cells (Fig. 1F), where depletion of LARG noticeably 
impaired actin cytoskeletal stress fibers. The number of actin stress fibers was quantified with 
ImageJ by measuring the peak fluorescent signal intensity in using the line profile tool, where 
distinct peaks in the fluorescent intensity represented individual stress fibers. Mechanical strain 
induced a significant (p<0.0001) increase of 1.71-fold in the number of stress fibers (Fig. 1G). 
Following LARG knockdown, no statistically significant differences in stress fiber numbers were 
observed (Fig. 1G). These data demonstrate that LARG, but not Vav2, is necessary for strain-
induced RhoA activity and actin remodeling in marrow derived MSCs.  
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LARG knockdown abrogates mechanical repression of adipogenesis through activation 
of RhoA  
 As we have previously shown that mechanical strain represses commitment of MSCs to the 
adipogenic lineage[6], and RhoA is a critical factor regulating MSC fate[5, 21], we sought to 
determine whether LARG was necessary for mechanical suppression of adipogenesis. 
mdMSCs cultured in adipogenic media for 3 days express adipogenic markers aP2, PPARγ, 
APN, and perilipin (Fig. 2A). Application of mechanical strain (2%, 10 cycles/min) for 6 hours per 
day for 3 days significantly suppressed expression of adipogenic markers APN by 2.82-fold (Fig. 
2B, p<0.05) and perilipin by 3.36-fold (Fig. 2C, p<0.01). Expression of aP2 (Fig. 2D) and PPARγ 
(Fig. 2E) were decreased by 1.47-fold and 1.76-fold respectively, compared to static controls, 
yet these values did not reach statistical significance. Cells depleted of LARG, via siRNA 
knockdown, demonstrated unaltered adipogenic commitment in response to mechanical strain 
(Fig. 1A-E). Additionally, under basal conditions (non-strained), the absence of LARG resulted 
in a significant increase in aP2 (1.94-fold, p<0.05, Fig. 2D) expression. Increases in APN (2.8-
fold, Fig. 2B), perilipin (1.6-fold, Fig. 2C), and PPARγ (1.04-fold, Fig. 2E) were observed, when 
compared to non-strained cells treated with a control siRNA, yet statistical significance was not 
reached for these values. When comparing expression of adipogenic markers in strained cells, 
with and without LARG, significant increases in APN (7.53-fold, p<0.01), perilipin (4.73-fold, 
p<0.001), aP2 (2.89-fold, p<0.01), and PPARγ (2.40-fold, p<0.05) were found following LARG 
knockdown (Fig. 2B-E). These data suggest that LARG is necessary for mechanical strain 
action to restrict MSC entry into the adipogenic lineage, and under basal conditions, LARG also 
restricts adipogenic fate of MSCs. 
Knockdown of ARHGAP18 enhances basal activation of RhoA 
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 Having determined that the GEF LARG regulates RhoA activity and lineage fate of MSCs, 
we shifted our attention to Rho GAPs, which inactivate RhoA. Previous work indicated that 
ARHGAP18 represses RhoA activity leading to impaired cell shape and motility[25]. We 
considered the contribution of ARHGAP in balancing RhoA activity in response to mechanical 
strain in MSCs. Stable shRNA-mediated knockdown of ARHGAP18 significantly (p<0.05) 
increased basal activation of RhoA by 3.54-fold (Fig. 3A), suggesting that ARHGAP18 tonically 
suppresses RhoA activity. When exposed to mechanical strain, both control MSCs (transfected 
with an empty vector), as well as cells in which ARHGAP18 was knocked down, showed 
significant increases in RhoA activity (Fig. 3A). While the activity of RhoA in ARHGAP18 
knockdown cells was greater following strain, activity in non-strained cells was also increased 
compared to cells with normal levels of ARHGAP18 expression. Strain induced a 3.54-fold 
increase in RhoA activity in shRNA control cells, but only a 2.83-fold increase (p<0.05) was 
observed following strain in ARHGAP18 knockdown cells. While there was a significant increase 
(p<0.05) in RhoA activity when comparing cells that were strained with shRNA control and cells 
strained with an shRNA targeting ARHGAP18, the increase in RhoA activity following strain in 
cells deficient in ARHGAP18 can be explained by the basal upregulation of active RhoA (Fig. 
3A), as knocking down ARHGAP18 increased RhoA activity in non-strained cells to about the 
equivalent of strained cells containing ARHGAP18. Staining with Alexafluor-488-conjugated 
phalloidin revealed increased actin stress fiber formation under basal (non-strained) conditions 
following ARHGAP18 knockdown (Fig. 3D) compared to cells with a control shRNA vector (Fig. 
3B), consistent with increased basal RhoA activity in the absence of ARHGAP18. While 
mechanical strain resulted in enhanced actin stress fiber formation (Fig. 3C), no additional 
increase was evident in strained MSCs in which ARHGAP18 was knocked down (Fig. 3E). Actin 
stress fiber numbers were quantified (Fig. 3F), where a significant increase in the number of 
actin stress was found following mechanical strain (1.56-fold p<0.0001). Consistent with RhoA 
data, knockdown of ARHGAP18, under non-strained conditions significantly increased actin 
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stress fiber number (1.71-fold, p<0.001). The number of actin stress fibers in cells depleted of 
ARHGAP18 following strain was 1.63-fold higher (p<0.01) than cells containing shRNA control 
and not strained; however, no statistically significant change was observed when compared to 
non-strained ARHGAP18 knockdown cells (Fig. 3F). Thus, ARHGAP18 regulates basal, but not 
mechanical formation of actin stress fibers by preserving RhoA activation. 
Knockdown of ARHGAP18 restricts entry into the adipocyte lineage 
 Both matrix stiffness[35] and cellular tension[21] direct MSC fate away from the adipogenic 
lineage. We hypothesized that enhanced cytoskeletal structure due to the absence of 
ARHGAP18 would restrict MSC adipogenesis. As expected, control MSCs formed abundant 
lipid droplets and expressed adipogenic markers (aP2, PPARγ, APN, and perilipin) when 
cultured for 3 days in adipogenic media (Fig. 4A). In contrast, shRNA knockdown of ARHGAP18 
suppressed adipogenesis, significantly reducing expression of adipogenic markers aP2 
(1,138.09-fold, p<0.05), PPARγ (10.57-fold, p<0.01), APN (193.74-fold, p<0.01), and perilipin 
(79.63-fold, p<0.05) compared to control cells in response to adipogenic media (Fig. 4B). 
Further, ARHGAP18 depleted MSCs had reduced oil-red-O staining (Fig. 4C-D). To determine if 
inhibition of adipogenesis was due to the effects of ARHGAP18 on RhoA, MSCs were treated 
with an inhibitor to block the downstream effects of RhoA activation. Addition of the Rho-
associated, coiled-coil containing protein kinase 1 (ROCK) inhibitor Y27632[36] partially rescued 
expression of APN following ARHGAP18 knockdown (Fig. 4E). 
Osteogenic potential of mdMSCs is enhanced in the absence of ARHGAP18 
 In culture, adipogenic commitment limits the pool of MSC progenitors available for 
osteogenesis[37]. To determine if ARHGAP18 influences osteogenic differentiation of MSCs, we 
cultured control and ARHGAP18 knockdown cells in osteogenic media containing ascorbic acid 
and β-glycerophosphate. An increase in alkaline phosphatase staining in ARHGAP18 
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knockdown cells was observed compared to controls at 7 days (Fig. 5A-B). Additionally, light 
microscopy showed formation of prominent osseous nodules in ARHGAP18 knockdown 
cultures at this time (Fig. 5D), whereas control MSCs lacked nodules at the same time point 
(Fig. 5C). In a previous study we showed that MSCs require 14 days in osteogenic conditions to 
generate bone nodules, with subsequent formation of osteocytes[38]. Thus, this observation 
suggests that ARHGAP18 knockdown accelerates formation of mineralized nodules in culture. 
 To further examine the role of ARHGAP18 in osteogenic differentiation, expression of 
osteogenic genes was assessed by qPCR analysis after 7 days in osteogenic media. 
Knockdown of ARHGAP18 resulted in a 2.5-fold increase (p<0.05) in osterix (Sp7) expression 
compared to control MSCs. Additionally, a 5-fold increase (p<0.01) in alkaline phosphatase 
(Alpl) and a 21-fold increase (p<0.01) in osteocalcin (Bglap) expression was observed following 
knockdown of ARHGAP18. Taken together with the alkaline phosphatase staining and formation 
of osseous nodules, these data demonstrate that deficiency of ARHGAP18 is associated with 
enhanced allocation of MSCs into the osteogenic lineage. 
Discussion 
 Bone health depends on the appropriate allocation of bone marrow mesenchymal 
progenitors, where increased adipogenic commitment leads to poor bone quality and 
quantity[39, 40]. Lineage decisions are influenced by cytoskeletal architecture, which is guided 
by cellular interaction with the static external physical environment[41]. Application of dynamic 
force, as might be applied to MSCs adherent to bone during exercise, induces activation of the 
Src-like kinase Fyn, which leads to mTORC2/Akt-mediated RhoA activation[5]. In this way, 
dynamic mechanical force generates an enhanced actin cytoskeletal structure, which, similarly 
to its effect in static conditions[21], suppresses adipogenesis. In this study we extend our 
understanding of the influence of RhoA signaling on MSC lineage fate by showing that the 
reciprocal control of RhoA is modulated by LARG and ARHGAP18. LARG is necessary for 
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dynamic mechanical activation of RhoA, while ARHGAP18 exerts a tonic control to restrain 
RhoA. Such regulatory control contributes to lineage biasing, where enhanced RhoA-mediated 
cytoskeletal structure represses adipogenesis and promotes osteogenesis. 
 In MSCs, Fyn cooperates with focal adhesion kinase (FAK) to regulate adipogenesis 
through actin cytoskeletal reorganization[5]. The contribution of FAK to marrow adiposity has 
been confirmed in vivo, where mice lacking FAK in osterix-expressing osteoblasts have 
increased accumulation of bone marrow fat with decreased osteogenic differentiation[42]. Our 
previous work revealed a critical role of Fyn/FAK on mTORC2/Akt signaling resulting in RhoA 
activation[5]. We now show that force-induced suppression of adipogenesis is abrogated in the 
absence of LARG, as knockdown of LARG interfered with mechanical repression of adipogenic 
markers APN, perilipin, and Pparγ. As Fyn/FAK, mTORC2, and Akt act upstream of RhoA[5], 
these signals likely converge on LARG to regulate the “on-state” of RhoA.  
 We also observed a significant increase in adipogenic commitment following LARG 
knockdown in the basal (non-strained) condition, suggesting that LARG is not only important for 
mechanical regulation of MSC functions, but also restricts entry into the adipogenic lineage. 
There was no significant decrease in RhoA activity in non-strained cells following LARG 
knockdown, nor were there significant changes in actin stress fiber numbers. It is possible that 
LARG depletion alters continual actin remodeling, or might influence other signaling pathways, 
independent of actin cytoskeletal structure, to modulate cellular differentiation. 
 RhoGAPs downregulate RhoA activity, cycling it back to the “off-state” [23]. In this study we 
focused on ARHGAP18, as it was shown to regulate motility, cell shape, and spreading of 
human MDA-MB-231 breast cancer cells through sustained RhoA activity and enhanced actin 
structure[25]. Indeed, knockdown of ARHGAP18 in MSCs enhances basal RhoA activity and 
consequent actin stress fiber formation. Although we hypothesized that knockdown of 
ARHGAP18 would reset RhoA to be more responsive to mechanical force, we did not find 
enhanced mechanical activation in its absence. These data suggest that either the mechanical 
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signal does not influence ARHGAP18 activity directly, or in the absence of ARHGAP18, RhoA is 
maximally activated, interfering with effects of a dynamic strain effect. Our actin stress fiber data 
support the latter conclusion, in that while ARHGAP18 knockdown, in non-strained cells, 
increased actin stress fiber number compared to cells containing a control shRNA, no increase 
in stress fiber number was seen in ARHGAP18 knockdown cells following strain. This suggests 
that the maximal number of actin stress fibers had been generated, such that strain had no 
effect to further change cellular stress. Knockdown of ARHGAP18 alone, however, caused a 
significant reduction in adipogenesis. These data demonstrate that ARHGAP18 plays a 
previously unrecognized role in regulation of MSC lineage fate, underscoring the importance of 
cytoskeletal structure in stem cell differentiation. In support of this regulatory function, we show 
that expression of APN, which was suppressed in ARHGAP18 deficient cells, was rescued by 
addition of the ROCK inhibitor Y27632. 
 Cytoskeletal structure is also important for osteoblast differentiation. When cultured in 
osteogenic media, ARHGAP18 deficient MSCs showed accelerated osteogenesis. Thus, our 
data suggest that ARHGAP18 regulation of RhoA activity in MSCs may function as a “lineage 
switch” capable of influencing skeletal homeostasis. As such, ARHGAP18 may represent a 
novel target to decrease bone marrow adiposity and promote skeletal health. 
 In summary, lineage decisions of marrow-derived MSCs are influenced by a wide-array of 
signals, including mechanical input. Application of mechanical force drives cellular rigidity 
through actin stress fiber formation, leading to adipogenic repression and promotion of 
osteogenesis. We here have identified two molecules that reciprocally regulate the activity of 
RhoA to influence MSC lineage. On one hand, LARG restricts adipogenesis and is necessary 
for mechanical and basal activation of RhoA, while ARHGAP18 promotes adipogenesis and 
suppresses osteogenesis via inhibition of RhoA activity. In conclusion, the balance of RhoA 
activity through GEF and GAP action has a role in determining the lineage fate of MSC 
progenitors. Targeting LARG or ARHGAP18 through physiological loading regimens or by 
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pharmacological means may prove a useful strategy to restrain adipose formation and promote 
skeletal integrity. 
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Figure Legends 
Figure 1. LARG is required for mechanical activation of RhoA in MSCs. (A) Mechanical 
treatment of mdMSCs (2% strain, 100 cycles) significantly (p<0.05, n=4) increased RhoA 
activation (RhoA-GTP). siRNA knockdown (20 nM) of LARG prevented strain-induced RhoA 
activation. (B) Knockdown of Vav2 did not influence strain-induced activation of RhoA, where 
mechanical strain significantly increased RhoA activity in the presence (p<0.05, n=3) and 
absence (p<0.01, n=3) of Vav2. (C-F) Staining of the actin cytoskeleton using alexa 488-
conjugated phalloidin showed increased stress fiber formation in strained cells (D) compared to 
static controls (C). siRNA knockdown of LARG, reduced the stress fiber formation following 
mechanical strain (F). (G) Quantification of stress fibers confirmed that strain significantly 
(p<0.0001) increased the number of stress fibers, whereas no significant increase was 
observed following knockdown of LARG. For actin quantification, at least 15 cells per condition 
total were analyzed across 3 independent experiments. 
 
Figure 2. LARG knockdown abrogates mechanical repression of adipogenesis. (A) Mechanical 
strain (2%, 6 hr/day, 3 days) of mdMSCs suppressed expression of APN, perilipin, aP2, and 
PPARγ. (B) Densitometry of Western blot bands demonstrates significant decreases in APN 
(p<0.05, n=6) and perilipin (C, p<0.01, n=6). While decreased following strain, expression levels 
of aP2 (p=0.34, n=6), nor PPARγ (p=0.17, n=6) reached statistical significance. Mechanical 
strain failed to suppress expression of any of these adipogenic markers following knockdown of 
LARG (B-E). 
 
Figure 3. Knockdown of ARHGAP18 enhances basal RhoA activation. (A) Strain significantly 
(p<0.05, n=3) increased RhoA activation (RhoA-GTP) following strain. Knockdown of 
ARHGAP18 resulted in increased basal activation of RhoA (p<0.05, n=3). RhoA activation was 
also significantly increased in the absence of ARHGAP18 following strain (p<0.05, n=3). (B-E) 
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mdMSCs were stained with Alexa488-conjugated phalloidin and dapi following strain (2%, 100 
cycles) (C, E) or under static conditions (B, D). Images were captured using a 20x 0.95 plan apo 
lens. Cells contained either a control shRNA vector (B, C) or an shRNA sequence targeting 
ARHGAP18 (D, E). (F) Quantification of stress fibers confirmed that strain significantly (p<0.05) 
increased the number of stress fibers under control conditions. The number of stress fibers was 
significantly (p<0.001) increased in cell deplete of ARHGAP18 compared to non-strained, 
ARHGAP18 replete cells. In ARHGAP18 knockdown cells, the number of stress fibers remained 
approximately equivalent to non-strained, ARHGAP18 knockdown cells, with no significant 
changes. For actin quantification, at least 15 cells per condition total were analyzed across 3 
independent experiments.  
 
Figure 4. Knockdown of ARHGAP18 suppresses mdMSC adipogenesis. (A) Western blots 
probing for adipogenic markers aP2, PPARγ, APN, and perilipin following knockdown of 
ARHGAP18. (B) Densitometry of radiograph bands from Western blots shows significantly 
decreased expression of aP2 (p<0.05, n=5), PPARγ (p<0.01, n=3), APN (p<0.01, n=5), and 
perilipin (p<0.05, n=3). (C, D) mdMSC cells stained with oil-red-O, with control shRNA or 
knockdown of ARHGAP18. (E) Western blot of APN following ARHGAP18 depletion and 
addition of ROCK inhibitor (Y27632, 10 μM). 
 
Figure 5. Osteogenic potential of mdMSCs is enhanced in the absence of ARHGAP18. (A, B) 
Alkaline phosphatase staining of control (A) and ARHGAP18 deplete (B) MSCs (10x 
magnification). Light microscopy (10x lens) of control (C) and ARHGAP18 knockdown cells after 
7 days in osteogenic media showing presence of mineralized nodules following ARHGAP18 
knockdown (D). qPCR analysis of osteogenic genes (E) Sp7 (osterix), (F) Alpl (alkaline 
phosphatase), and Bglap (osteocalcin) in control and ARHGAP18 knockdown mdMSCs. 
*p<0.05, **p<0.01, n=3 for all assays.  
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Highlights 
 
 LARG, a Rho GEF, is necessary for mechanical activation of RhoA. 
 Knockdown of LARG prevents mechanical suppression of adipogenesis. 
 ARHGAP18, a Rho GAP, restricts RhoA to restrain entry into the osteogenic lineage. 
 ARHGAP18 knockdown increases actin fibers and decreases adipogenic differentiation. 
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